Ipamorelin is the amplifier: it opens a second gate so the same GHRH drive translates into a bigger release, while its selectivity keeps cortisol and prolactin largely out of the picture
The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
Individuals were excluded if they had a vasectomy, Y-chromosome microdeletions, Klinefelter syndrome, cystic fibrosis, physical impairments leading to infertility, or used fertility-related medicines in the past six months
Week 48 What you may notice: Measurable reduction in body fat
Also known as cobalamin, this nutrient is a powerhouse, playing a key role in everything from your energy production to your brain function and the creation of red blood cells
From REDEFINE-1: Nausea: 55% of CagriSema participants vs 12.6% with placebo Constipation: 30.7% vs 11.6% Vomiting: 26.1% vs 4.1% Discontinuation rate: 5.9% vs 3.5% placebo comparable to Wegovy (6.9%) and Zepbound (6.2%) The nausea rate (55%) is higher than the ~4045% typical for semaglutide alone